Real-Time Benefit Tools for Drug Prices
Author:
Affiliation:
1. School of Medicine, Department of Health Policy, Vanderbilt University, Nashville, Tennessee
2. School of Medicine, Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2753854/jama_everson_2019_vp_190142.pdf
Reference5 articles.
1. Lowering cost and increasing access to drugs without jeopardizing innovation.;Califf;JAMA,2019
2. Technology, incentives, or both? factors related to level of hospital health information exchange.;Lin;Health Serv Res,2018
3. The effect of medication cost transparency alerts on prescriber behavior.;Monsen;J Am Med Inform Assoc,2019
4. Paper- and computer-based workarounds to electronic health record use at three benchmark institutions.;Flanagan;J Am Med Inform Assoc,2013
5. Centers for Medicare & Medicaid Services (CMS), HHS. 42 CFR Parts 422 and 423: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses. Federal Register website. https://www.federalregister.gov/documents/2019/05/23/2019-10521/modernizing-part-d-and-medicare-advantage-to-lower-drug-prices-and-reduce-out-of-pocket-expenses. Published May 23, 2019. Accessed August 31, 2019.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Health care systems, social adversity, and precision medicine;Comprehensive Precision Medicine;2024
2. Associations between the use of a real-time benefit tool and measures related to prescription obtainment found in order type subgroups;Journal of the American Pharmacists Association;2023-11
3. Quality of Medication Cost Conversations and Interest in Future Cost Conversations Among Older Adults;Journal of General Internal Medicine;2023-09-14
4. Impact of a Standardized, Pharmacist-Initiated “Test-Claim” Workflow for Anticipating Barriers to Accessing Discharge Antimicrobials;Journal of Pharmacy Technology;2023-09-02
5. Implementing real-time prescription benefit tools: Early experiences from 5 academic medical centers;Healthcare;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3